دورية أكاديمية

mir-129-5p and Let-7 are Down-Regulated in Carcinoid Tumors.

التفاصيل البيبلوغرافية
العنوان: mir-129-5p and Let-7 are Down-Regulated in Carcinoid Tumors.
المؤلفون: Døssing, K., Binderup, T., Kaczkowski, B., Jacobsen, A., Winther, O., Rossing, M., Federspiel, B., Knigge, U., Kjaer, A., Friis-Hansen, L.
المصدر: Neuroendocrinology; Jul2012 Supplement, Vol. 96, p2-3, 2p
مصطلحات موضوعية: RNA, GENETIC regulation, MESSENGER RNA, GENE expression, CANCER genetics, CARCINOGENESIS, NEUROENDOCRINE tumors, METASTASIS
مستخلص: Introduction: miRNAs are small non-coding RNAs that post-transcriptionally regulate gene expression by binding to comple mentary sequences on target mRNAs and their expression is often dysregulated in cancer. Aim(s): Little is known about the carcinogenesis of the slow growing neuroendocrine tumors and we therefore wanted to characterize miRNA expression in these. Materials and methods: miRNA expression in carcinoids, metastasis and normal intestinal tissue was characterized using miRNA arrays. Changes in miRNA expression were validated by in-situ hybridization and qPCR. miR-129-Sp and let-7 was selected and further characterized by mRNA arrays on total RNA from cells transfected with either miRNA. Heatmaps identified let-7 target genes involved in metastasis, miR-129-5p and its two targets EGR1 and G3BP 1 were validated by western blot analysis and luciferase assay and further examined by growth assays with ceils transfected with miR-129-5p or siRNAs against EGR1 and G3BP1. Results: miR-129-5p is down-regulated in carcinoids and the let-7 family is reduced in metastasis. When transfected into carcinoid cells, both Let-7 and miR-129-5p inhibited their growth and miR-129-5p was shown to target EGR1 and G3BP1. Knock down of EGR1 and G3BP 1 also resulted in growth inhibition mimicking that of miR-129-5p. Conclusion: miRNA expression alters intestinal carcinoids, leading to down regulation of miR-129-5p, and the let-7 family is lost in metastasis. Both are important for growth inhibition. [ABSTRACT FROM AUTHOR]
Copyright of Neuroendocrinology is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index